Crossref
SGLT2 Inhibitors in Kidney Transplant Recipients: Promising Signals, But Limited Evidence
Clinical Diabetology · 28.04.2026
DOI: 10.5603/cd.112125 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Diabetology, online erschienen am 28.04.2026. Verfasst von Jacek Kubica und 1 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Kubica, J., & Kubica, A. (2026). SGLT2 Inhibitors in Kidney Transplant Recipients: Promising Signals, But Limited Evidence. Clinical Diabetology. https://doi.org/10.5603/cd.112125
Vancouver
Kubica J, Kubica A. SGLT2 Inhibitors in Kidney Transplant Recipients: Promising Signals, But Limited Evidence. Clinical Diabetology. 2026. doi:10.5603/cd.112125
BibTeX
@article{Kubica2026,
author = {Kubica, Jacek and Kubica, Aldona},
title = {SGLT2 Inhibitors in Kidney Transplant Recipients: Promising Signals, But Limited Evidence},
journal = {Clinical Diabetology},
year = {2026},
doi = {10.5603/cd.112125}
}
EUVIMED